About the Cluster

About the Cluster

The Cluster of Excellence "Image-guided and Functionally Instructed Tumor Therapies (iFIT)" aims to achieve a comprehensive understanding of biological processes in tumors in order to develop innovative and sustainable cancer therapies. The iFIT Cluster of Excellence is the only oncology cluster of excellence in Germany. At the beginning of 2026 iFIT entered its second funding phase after its initial founding January, 2019.
At the iFIT Cluster of Excellence internationally renowned scientists and talented young researchers work together in this consortium in a globally unique collaboration of three different research areas here in Tuebingen to shape the future of cancer research.

News

News

iFIT Distinguished Lecture

October 26, 2026, 12:00pm, with Dr. Sara Lacerda

Learn more

Invited Talk: Juliane Walz at ESMO

Principles of Therapeutic Cancer Vaccination

Learn more

PhD Retreat Schloss Döttingen

October 19-20, 26 two days of networking, recreation and exchange

Learn more

Events

iFIT Distinguished Lecture

November 9, 2026 with Dr. Korbinian Kropp

Learn more

iFIT Workshop Scientific Writing

November 12-13, with Dr. Birgit Hollenbach

Learn more

iFIT Strategy and SAB Meeting 2026

November 19–21, 2026, Hotel Vier-Jahreszeiten, Schluchsee

Learn more

Scientific Symposium & MerryScience

Dec. 8, 2026 Lecture Hall & Mensa, Women's Hospital, Tübingen

Learn more

2nd international iFIT Conference

November 17 - 19, 2027 - Congress Center Innsbruck, Austria

www.ifit-conference.com

Join our Cluster!

Check out our job vacancies!

Cancer research at the highest level

iFIT in figures

3
research areas
16
Institutional partners
> 800
publications (as of December 2025)
~ 260
involved scientists

Subscribe to our iFIT Newsletter!

We want to inform everyone who is involved with or interested in the Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies" (iFIT) about recent developments, upcoming activities, and other general iFIT-related topics surrounding the future of cancer research made in Tuebingen.

Newsletter Archiv